Patents by Inventor Shi-Liang Tseng

Shi-Liang Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processes for producing amide compounds, and their crystalline and salt form
    Publication number: 20230131180
    Abstract: Disclosed is processes for producing amide compounds, and their crystalline and salts form. Herein, one of the amide compounds is represented by the following formula (1): which is characterized by an X-ray diffraction (XRD) pattern having peaks at about 14.2, 15.6, 16.4, 20.1, 20.5 and 21.2°±0.2° 2?.
    Type: Application
    Filed: March 3, 2021
    Publication date: April 27, 2023
    Inventors: Cheng-Ho CHUNG, Shi-Liang TSENG, Hsiang-En HSU
  • Amide compounds and use thereof
    Patent number: 11384060
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: (I), in which each of variables R1, R2, R3, R4, R5, A1, A2, A3, A4, X and Y is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: July 12, 2022
    Assignee: ALPHALA CO., LTD.
    Inventors: Cheng-Ho Chung, Shi-Liang Tseng, Yung-Ning Yang, Yen-Fu Chen
  • Compound and pharmaceutical composition containing the same
    Patent number: 11174253
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: Formula (I), in which each of variables L, R3, R4, Y, Z1, Z2 and Z3 is defined herein. Also disclosed is a method for treating a cancer with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: November 16, 2021
    Assignee: ALPHALA CO., LTD.
    Inventors: Cheng-Ho Chung, Shi-Liang Tseng, Yen-Fu Chen, Jian-Bin Lee
  • Amide compounds and use thereof
    Patent number: 10882837
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R1, R2, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: January 5, 2021
    Assignee: ALPHALA CO., LTD.
    Inventors: Cheng-Ho Chung, Shi-Liang Tseng, Yung-Ning Yang, Yen-Fu Chen
  • Novel compound and pharmaceutical composition containing the same
    Publication number: 20200172531
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: Formula (I), in which each of variables L, R3, R4, Y, Z1, Z2 and Z3 is defined herein. Also disclosed is a method for treating a cancer with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Application
    Filed: August 1, 2018
    Publication date: June 4, 2020
    Inventors: Cheng-Ho CHUNG, Shi-Liang TSENG, Yen-Fu CHEN, Jian-Bin LEE
  • AMIDE COMPOUNDS AND USE THEREOF
    Publication number: 20190345118
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R1, R2, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Application
    Filed: January 22, 2018
    Publication date: November 14, 2019
    Inventors: Cheng-Ho CHUNG, Shi-Liang TSENG, Yung-Ning YANG, Yen-Fu CHEN
  • AMIDE COMPOUNDS AND USE THEREOF
    Publication number: 20190337915
    Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: (I), in which each of variables R1, R2, R3, R4, R5, A1, A2, A3, A4, X and Y is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.
    Type: Application
    Filed: January 22, 2018
    Publication date: November 7, 2019
    Inventors: Cheng-Ho CHUNG, Shi-Liang TSENG, Yung-Ning YANG, Yen-Fu CHEN
  • PYRAZOLE COMPOUNDS
    Publication number: 20090042864
    Abstract: This invention relates to pyrazole compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.
    Type: Application
    Filed: October 2, 2007
    Publication date: February 12, 2009
    Applicant: National Health Research Institutes
    Inventors: Kak-shan Shia, Chia-Liang Tai, Jing-po Tsao, Wan-ping Hsieh, Shi-Liang Tseng, Yu-Sheng Chao, Ming-shiu Hung
  • PYRAZOLE COMPOUNDS
    Publication number: 20080090809
    Abstract: This invention relates to pyrazole compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.
    Type: Application
    Filed: October 2, 2007
    Publication date: April 17, 2008
    Applicant: National Health Research Institutes
    Inventors: Kak-Shan Shia, Chia-Liang Tai, Jing-po Tsao, Wan-ping Hsieh, Shi-liang Tseng, Yu-Sheng Chao, Ming-Shiu Hung
  • Aminothiol compound
    Patent number: 7335781
    Abstract: The present invention discloses an aminothiol compound having a general formula I wherein R1-R5 are substitutable ligands. Such compound can perform as a superior catalyst in an asymmetric addition reaction of organic metal compounds and aldehyde. According to the present invention, the aminothiol compound is needed only less than 0.02% based on main reactants to obtain enantioselectivity higher than 98% enantiomeric excess, whereby the asymmetric reactions can become very economic.
    Type: Grant
    Filed: March 23, 2004
    Date of Patent: February 26, 2008
    Assignee: Huey Jiin Co., Ltd.
    Inventors: Teng-Kuei Yang, Shi-Liang Tseng, To Liu, Nan-Kuang Chen
  • Aminothiol compound
    Publication number: 20040181057
    Abstract: The present invention discloses an aminothiol compound having a general formula I wherein R1-R5 are substitutable ligands. Such compound can perform as a superior catalyst in an asymmetric addition reaction of organic metal compounds and aldehyde. According to the present invention, the aminothiol compound is needed only less than 0.02% based on main reactants to obtain enantioselectivity higher than 98% enantiomeric excess, whereby the asymmetric reactions can become very economic.
    Type: Application
    Filed: March 23, 2004
    Publication date: September 16, 2004
    Inventors: Teng-Kuei Yang, Shi-Liang Tseng, To Liu, Nan-Kuang Chen